Skip to main content

Table 2 Estimated hepatitis C virus seroprevalence and estimated number of seropositive individuals, 2013–2014, Belgium

From: Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

Demographic characteristic HCV seropositivity 2013–2014
Number in study sample Prevalence in Belgium Individuals in Belgium
% 95% CI n 95% CI
Sex Female 2 0.13 0.03–0.59 7200 1510–33,520
Male 4 0.32 0.1–1.03 17,450 5370–56,380
Region Brussels-Capital 2 1.05 0.35–3.15 12,180 4020–36,320
Flanders 4 0.21 0.07–0.66 13,300 4180–42,180
Wallonia 0 0 0–0.46 0 0–16,390
Age group (in years) < 20 1 0.08 0.01–0.54 1990 290–13,700
≥20 5 0.26 0.10–0.64 22,220 8890–55,420
  20–29 0 0 0–0.98 0 0–13,670
30–39 1 0.31 0.04–2.27 4490 600–32,890
40–49 1 0.13 0.02–1.14 2150 250–18,230
50–59 2 0.74 0.16–3.41 11,240 2380–52,030
60–69 1 0.44 0.06–3.34 5290 680–40,260
70–79 0 0 0–4.51 0 0–36,840
≥80 0 0 0–3.66 0 0–21,490
All   6 0.22 0.09–0.54 24,420 9990–59,940
  1. Legend: HCV: hepatitis C virus, CI: confidence interval